Thursday, July 28, 2011

Oncogene - Table of Contents alert Volume 30 Issue 30

TABLE OF CONTENTS

Volume 30, Issue 30 (July 2011)

In this issue
Review
Original Articles

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Continuing a tradition of excellence

Oncogene, now in its 24th year of publication, continues to present the most essential developments in cancer research.

Visit Oncogene’s website now!
 

Review

Top

Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients

C Lee and V D Longo

Oncogene 2011 30: 3305-3316; advance online publication, April 25, 2011; 10.1038/onc.2011.91

Abstract | Full Text

Original Articles

Top

Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest

H D Kim, T-S Kim and J Kim

Oncogene 2011 30: 3317-3327; advance online publication, March 7, 2011; 10.1038/onc.2011.47

Abstract | Full Text

Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα

K B Grandinetti, T A Stevens, S Ha, R J Salamone, J R Walker, J Zhang, S Agarwalla, D G Tenen, E C Peters and V A Reddy

Oncogene 2011 30: 3328-3335; advance online publication, March 14, 2011; 10.1038/onc.2011.57

Abstract | Full Text

Non-canonical β-catenin degradation mediates reactive oxygen species-induced epidermal cell death

E Omori, K Matsumoto and J Ninomiya-Tsuji

Oncogene 2011 30: 3336-3344; advance online publication, March 7, 2011; 10.1038/onc.2011.49

Abstract | Full Text

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

J H Oh, M-C Cho, J-H Kim, S Y Lee, H J Kim, E S Park, J O Ban, J-W Kang, D-H Lee, J-H Shim, S B Han, D C Moon, Y H Park, D-Y Yu, J-M Kim, S H Kim, D-Y Yoon and J T Hong

Oncogene 2011 30: 3345-3359; advance online publication, March 21, 2011; 10.1038/onc.2011.52

Abstract | Full Text

A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor

M Lee, M J Daniels, M J Garnett and A R Venkitaraman

Oncogene 2011 30: 3360-3369; advance online publication, March 14, 2011; 10.1038/onc.2011.55

Abstract | Full Text

A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling

B F Clem, A L Clem, A Yalcin, U Goswami, S Arumugam, S Telang, J O Trent and J Chesney

Oncogene 2011 30: 3370-3380; advance online publication, March 21, 2011; 10.1038/onc.2011.51

Abstract | Full Text

Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors

C J Guigon, D W Kim, M C Willingham and S-y Cheng

Oncogene 2011 30: 3381-3390; advance online publication, March 14, 2011; 10.1038/onc.2011.50

Abstract | Full Text

Advertisement

Call for papers!

Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.

Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: